National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

No judgment structure available for this case.

STATUTORY RULES

1967 No.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1967.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1967.

Dated this twenty-fourth day of August, 1967.

CASEY

Governor-General.

By His Excellency’s Command,

(SGD.) A. J. FORBES

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits)

Regulations

Commencement.

1. These Regulations shall come into operation on the first day of September, 1967.

First Schedule.

2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by inserting after the words “ Almond Oil.” the words “ Aluminium Hydroxide Tablets.”; and
(b) by inserting after the word “ Chlorpropamide.” the words “ Cholera Vaccine.”.

Second Schedule.

3. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting the words—
“ Lissapol	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Hexachlorophane B.P. with Lissapol ”;
(b) by omitting the words—
“ Neomycin Sulphate, B.P.	Hydrocortisone Acetate, B.P. with Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Kaolin B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin ”
and inserting in their stead the words—
“ Neomycin Sulphate, B.P.	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate B.P.
Neomycin Sulphate B.P. with Kaolin B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin

* Notified in the Commonwealth Gazette on 1967.

Statutory Rules 1960, No, 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; and 1967, No. 67.

10275/67—Price 20c 10/8.8.1967

(c) by inserting before the words—
“ Methylprednisolone, B.P.	__ ”
the words—
“ Polyvinyl Alcohol	— ”; and
(d) by inserting before the words—
“ Tetanus Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.	Diphtheria and Tetanus Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.”
the words—
“ Terric	Hexachlorophane B.P. with Terric
Terric with Spearmint Oil B.P.C. and Cetrimide B.P.”.

Third Schedule.

4. The Third Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by omitting the word “ Aloxidone.”;
(b) by inserting after the words—
“ Ferrous Succinate.”
the words—
“ Fluphenazine Hydrochloride.
Fluphenazine Oenanthate.”;
(c) by omitting the word “ Lissapol.”;
(d) by inserting after the word—
“ Polythiazide.”
the words—
“ Polyvinyl Alcohol.”;
(e) by inserting after the words and figures—
“ Tartrazine, B.P.C. 1954.”
the word—
“ Terric”; and
(f) by inserting after the word—
“ Thiotepa.”
the words—
“ Thonzonium Bromide.
Thonzylamine Hydrochloride.”.

Fourth and Fifth Schedules.

5. The Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

FOURTH SCHEDULE

Regulation 12.

Additives

Acetone, B.P.C.
Alcohol (95%), B.P.
Arachis Oil, B.P.
Amethocaine Hydrochloride, B.P.
Camphor, B.P.
Caraway Oil, B.P.C.
Carmine Solution, A.P.F.
Citronella Oil, B.P.C.
Chloroform, B.P.
Cottonseed Oil, B.P.
Dextrose, B.P.

Fourth Schedule—continued
Dextrose Monohydrate, B.P.
Dilute Alcohols, B.P.
Ether Anaesthetic, B.P.
Honey—Purified
Maize Oil, B.P.
Olive Oil, B.P.
Pilocarpine Hydrochloride
Saccharin Sodium, B.P.
Sodium Thiosulphate, B.P.C.
Solution of Burnt Sugar, B.P.C. 1959
Spirit Methylated, Industrial
Xylene, B.P.C. 1949

FIFTH SCHEDULE

Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Acetylcysteine................................	Fibrocystic Disease
Acetylsalicylic Acid Tablets, B.P.....
Soluble Acetylsalicylic Acid Tablets
B.P.................................................	Any disease or condition in a pensioner
Acetylsalicylic Acid with Paracetamol and Caffeine Tablets
Acrylic Resin.................................	Ileostomy or colostomy conditions
Aldosterone....................................	With the written authority of the Director-General, treatment of an actute crisis in—
Addison’s disease
Salt-losing congenital adrenal hypoplasia
Allopurinol.....................................	Chronic gout not responding to other pharmaceutical benefits
Aminocaproic Acid.........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Amino Acids..................................
Amitriptyline Tablets, B.P...............	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Amphetamine Sulphate Tablets, B.P.	Any disease or condition in a pensioner
Amphotericin B..............................	Systemic fungal infection
Ampicillin Capsules, B.P................	With the written authority of the Director-General—
Ampicillin Injections, Tablets and Suspension	Gram-negative infections in pregnant women Infections, in children under the age of five years, in which penicillin and sulphonamides are not effective.
Aneurine Hydrochloride Tablets B.P.	Any disease or condition in a pensioner
Angiotensin Amide.........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ascorbic Acid Tablets, B.P.............	Any disease or condition in a pensioner

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Azathioprine..................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Beclamide.....................................
Benzoin Compound Tincture, B.P.C.	Ileostomy and Colostomy conditions
Betamethasone Tablets.................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Betamethasone Sodium Phosphate	Intra-articular use
Injection, B.P.
Busulphan Tablets, B.P................	Leukaemia
Any disease or condition in a pensioner
Calciferol Tablets, B.P..................	With the written authority of the Director-General—
Calciferol, B.P..............................	Hypoparathyroidism
Chronic hypoparathyroid tetany
Vitamin D-resistant rickets
Calcium Aminosalicylate..............	Tuberculosis
Calcium Gluconogalactogluconate	Hypoparathyroidism
Effervescent Tablets
Carbamazepine..............................	Epilepsy
Trigeminal neuralgia
Carbenoxolone Sodium................	Any disease or condition in a patient receiving treatment
Cephaloridine................................	in or at an approved hospital
Chlorambucil Tablets, B.P.	Malignant lymphoma and related conditions
Chloramine Deodorant Tablets and Powder	Ileostomy or colostomy conditions
Chloramphenicol Capsules, B.P...	Bacterial meningitis Haemophilus influenzae infections Intra-ocular infections Rickettsial infections Salmonella septicaemia Typhoid and paratyphoid Other serious infections sensitive only to Chloramphenicol
Chloramphenicol Injections..........
Chloramphenicol Tablets..............	A disease or condition specified m this column in relation to
Chloramphenicol Oral Suspension	Chloramphenicol Capsules
Chlorotrianisene Tablets...............	Carcinoma of the prostate
Chloropromazine Hydrochloride..	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment In or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
Huntington’s chorea
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride, or Nortriptyline Hydrochloride
Chlortetracycline Capsules, B.P...	Brucellosis Herpes zoster ophthalmicus Intestinal amoebiasis Leptospirosis Lymphogranuloma venereum Psittacosis Rickettsial infections

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII, of the Act
Chlortetracycline Capsules B.P.— continued	Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
Chlortetracycline Hydrochloride Granules...................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Cloxacillin Sodium, B.P...............	Any disease or condition in a patient receiving treatment in or at an approved Hospital
Cloxacillin Capsules, B.P.............
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets
Codeine Phosphate with Acetylsalicylic Acid Tablets
Codeine Phosphate with Acetylsalicylic Acid and Paracetamol soluble Tablets	Any disease or condition in a pensioner
Codeine Phosphate with Acetylsalicylic Acid, Paracetamol and Caffeine Tablets
Cod Liver Oil Emulsion................	Any disease or condition in a child under the age of twelve years or in a pensioner
Colistin Sulphomethate Injection, B.P.	Pyocyaneus infection and Gram-negative infections where no other drug is effective
Corticotrophin Injection, B.P........	With the written authority of the Director-General—
Corticotrophin Gelatin Injection, B.P.	A disease or condition specified in this column in relation to Cortisone Injection
Corticotrophin Zinc Hydroxide	Hypsarrhythmia
Injection, B.P.	Salaam convulsions
Cortisone Injection, B.P................	The prevention of side effects of corticosteroid therapy With the written authority of the Director-General—
Acute exophthalmic ophthalmoplegia Acute heart block complicating myocardial infarction Anaemia, acquired haemolytic Addison’s disease Adrenocortical hypoplasia Adrenalectomy, total Adrenogenital syndrome Agranulocytosis Behcet’s syndrome Benign intracranial hypertension Cerebral tumours and cerebral oedema Cranial arteritis Cushing’s syndrome, including hyperadrenocorticalism Dermatitis, acute exfoliative Dermatomyositis Encephalitis Encephalomyelitis Encephalomyelitis, acute disseminated Guillain-Barré syndrome Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis Hansen’s disease Hepatitis, progressive or continuing, proven by biopsy or biochemistry Hodgkin’s disease Idiopathic hypercalcaemia Inflammatory conditions of the uveal tract and retina Interstitial Keratitis due to syphilis or vernal conjunctivitis Keratoplasty Leucine-sensitive hypoglycaemia Leukaemia Lymphosarcoma and follicular lymphoma Meningitis Metastatic breast cancer

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Cortisone Injection, B.P.—continued	Mycosis fungoides Nephrosis or nephrotic syndrome Neuromyelitis optica Oedema of the spinal cord following trauma or infection Opticneuritis following removal of tumor of the brain Panhypopituitarism Pemphigus Periarteritis nodosa Progressive transverse myelitis Pseudohermaphroditism Purpua, Henoch’s Purpura, thrombocytopenic Regional ileitis (Crohn’s disease) Reticulum cell sarcoma Rheumatic carditis, acute Sarcoidosis Scleroderma Severe reactions of the skin and mucosa following X-ray therapy Splenic neutropenia Status asthmaticus Steroid therapy prior to operation in patients under steroid therapy Stevens-Johnson syndrome Still’s disease in a child under the age of sixteen years Sympathetic ophthalmitis Systemic lupus erythematosus Temporal arteritis Treatment of malignancy in conjunction with radiotherapy or chemotherapy Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases Type II Nephritis Ulcerative colitis proven by sigmoidscopy or radiological report
Cortisone Tablets, B.P..................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection, B.P....	Established megalocytic anaemia Neuroblastoma Subacute combined degeneration of the cord
Cymogran......................................	With the written authority of the Director-General, phenylketonuria
Cycloserine Tablets, B.P.............. Cycloserine Capsules, B.P............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Demethylchlortetracycline Capsules, B.P. Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
Demethylchlortetracycline Hydrochloride with Nystatin	Any disease or condition specified in this column in relation to Oxyletracycline Hydrochloride with a buffering agent and Nystatin
Deodorant Detergent Solution (Terric with Spearmint Oil and Cetrimide)	Ileostomy or colostomy conditions
Deoxycortone Aqueous Injections Deoxycortone Acetate Injection, B.P. Deoxycortone Trimethylacetate Injection, B.P. Deoxycortone Acetate Implants, B.P. Deoxycortone Acetate Tablets......	Addison’s disease Adrenalectomy, total

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Desferrioxamine............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dexamethasone Tablets, B.P........	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Dexamethasone Sodium Phosphate Injections	Intra-articular use
Dexamphetamine Tablets, B.P.....	Any disease or condition in a pensioner
Diazepam Injection, Syrup and 10 mg. tablet	Epilepsy
Diazepam Tablets 2 mg. and 5 mg.	Epilepsy
Treatment in multiple sclerosis
Dienoestrol Cream........................	Any disease or condition in a pensioner
Dienoestrol Tablets, B.P...............	Carcinoma of the prostate Mammary carcinoma Any disease or condition in a pensioner
Dihydrostreptomycin Sulphate Injection	As an- alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol.......................	Parathyroid deficiency
Diloxanide Furoate Tablets, B.P...	Amoebic dysentery
Dimethicone..................................	Ileostomy or colostomy conditions
Disodium Stilboestrol Diphosphate	Carcinoma of the prostate
Dithiazanine Iodide......................	Infestations of Trichuris trichiura or Strongyloides stercoralis
Ditophal........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Erythromycin................................	Brucellosis Intestinal amoebiasis Leptospirosis Lymphogranuloma venereum Mycoplasma pneumoniae (Eaton’s Agent) Psittacosis Rickettsial infections Staphylococcal septicaemia or staphylococcal pneumonia Any bacterial infections or spirochaetal infection or actinomycosis or trachoma where those cannot be treated safely and effectively by sulphonamides or penicillins Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
Ethinyloestradiol Tablets, B.P......	Any disease or condition in a pensioner Hereditary telangiectasis Pre-menopausal castration syndrome Turner’s syndrome
Ethionamide..................................	Tuberculosis
Ethisterone Tablets, B.P...............	Turner’s syndrome
Ethyloestrenol...............................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Fludrocortisone Tablets, B.P........	Addison’s disease Adrenocortical hypoplasia Total adrenalectomy
Fluorouracil Sodium.....................	Carcinoma of the colon and rectum
Fluoxymesterone Tablets, B.P......	Castration syndrome (male) Mammary carcinoma With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Fluphenazine Oenanthate Injection Fluphenazine Hydrochloride Elixir Fluphenazine Hydrochloride Tablets and Injection	A disease or condition specified in this column in relation to Chlorpromazine Hydrochloride
Folic Acid Injection...................... Folic Acid Tablets, B.P.................	Marcrocytic anaemia Sprue or the sprue-like syndrome
Folinic Acid..................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Framycetin Sulphate Tablets.........	Bowel sterilization preparatory to major surgery

Fifth Schedule—continued

Pharmaceutical Benefits

Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

Fusidic Acid (Sodium Salt or Diethanolamine Salt)................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Fusidic Acid (Sodium Salt or Diethanolamine Salt) is the only appropriate antibiotic
Galactomin Formula No. 11.........	With the written authority of the Director-General— Galactosaemia Conditions needing an extreme restriction of lactose in the patient’s diet, in children under the age of four years
Goats Milk, dehydrated................	With the written authority of the Director-General, cows milk allergy in children under the age of four years
Griseofulvin Tablets, B.P.............	With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination
Halibut Liver Oil Capsules...........	Any disease or condition in a pensioner
Hexachlorophane with Entsufon.. Hexachlorophane with Lissapol.... Hexachlorophane in Soap Solution	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hydrocortisone Injection..............	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Acetate Injection, B.P...................................................	Intra-articular use
Hydrocortisone Sodium Succinate Injection...................................	Acute adrenal failure due to medical or surgical crises Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy
Stevens-Johnson syndrome
Hydroxocobalamin Injection, B.P.	Established megalocytic anaemia Neuroblastoma Sub-acute combined degeneration of the cord
Hydroxypregesterone....................	Endometrial carcinoma Habitual abortion Progesterone deficiency proven by hormonal assay of lateral wall smear
Idoxuridine...................................	Infections caused by Herpes Simplex Virus
Imipramine Tablets, B.P...............	Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortiriptyline Hydrochloride
Indomethacin Capsule...................	Rheumatoid arthritis or osteroarthritis not responding to salicylates
Isoniazid Tablets, B.P...................	Acute attacks of gout Tuberculosis
Kanamycin Sulphate Capsules, Injections and Oral Solution	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic
Kitasamycin..................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Levorphanol Tartrate....................	Obstetrical use Severe intractable pain

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Lincoroycin Hydrochloride..........	Osteomyelitis Pneumococcal Meningitis
Liothyronine Tablets, B.P.............	Myxoedema Myxoedema coma
Lipopancreatin..............................	Any disease or condition in a patient receiving treatment in or at an approved Hospital
Lofenalac......................................	With the written authority of the Director-General, phenylketonuria
Medroxyprogesterone Acetate Tablets	Endometrial carcinoma
Medroxyprogesterone Acetate Injections..................................................	Endometrial carcinoma Progesterone deficiency proven by hormonal assay of lateral wall smear
Melphalan......................................	Malignant melanoma Multiple myeloma
Mercaptopurine Tablets, B.P........	Allergic angiitis Leukaemia Lupus erythematosus Nephrosis or Nephrotic syndrome Periarteritis
Mestandone...................................	Mammary carcinoma With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Methacycline.................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
Methandienone Tablets, B.P......... Methenolone Acetate....................	With the written authority of the Director-General, Intermittent use for corticosteroid-induced osteoporosis
Methicillin Sodium....................... Methicillin Injection, B.P.............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methotrexate Tablets..................... Methotrexate Injections................	Leukaemia and neoplastic disease Any disease or condition in a patient receiving treatment in or at an approved hospital
Methylamphetamine Injection, B.P. Methylamphetamine Tablets, B.P.	Any disease or condition in a pensioner
Metyrapone...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Minafen.........................................	With the written authority of the Director-General, phenylketonuria
Morphine Sulphate, B.P. with Tacrine Tablets	Severe intractable pain
Mustine Hydrochloride Injection..	Malignant lymphoma and related conditions
Nalidixic Acid..............................	With the written authority of the Director-General, urinary tract infections
Nandrolone Phenylpropionate Injection, B.P............................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Nandrolone Decanoate	Mammary carcinoma With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Neomycin Sulphate, B.P. with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate, B.P.	Any disease or condition in a pensioner
Neomycin Tablets, B.P.	Bowel sterilization preparatory to major surgery Portal-systematic encephalopathy
Nicotinic Acid Tablets, B.P..........	Any disease or condition in a pensioner
Nitrofurantoin Tablets, B.P.......... Nitrofurantoin Oral Suspension....	Urinary tract infections
Nitromin........................................	Malignant lymphoma and related conditions

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Nortriptyline Hydrochloride, B.P. Nortriptyline Tablets, B.P............. Nortriptyline Capsules, B.P..........	Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which lie received treatment for a mental disorder and who is living in a place remote from an approved hospital The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Nutramigen...................................	With the written authority of the Director-General— Cows milk allergy in children under the age of four years Galactosaemia Lactose intolerance Fibrocystic disease of the pancreas in children under the age of four years
Nystatin Tablets, B.P....................	Monilia infections
Orciprenaline Sulphate Injection.. Orciprenaline Sulphate Solution for Inhalation	Any disease or condition in a patient receiving treatment in or at any approved hospital
Oxycodone Pectinate....................	Late-stage malignancy
Oxymesterone...............................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Oxytetracycline Hydrochloride Capsules.................................................. Oxytetracycline Tablets, B.P........ Oxytetracycline Injections Calcium di-Oxytetracycline Oral Suspension Calcium di-Oxytetracycline Paediatric Drops	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Oxytetracycline Hydrochloride with a buffering agent and Nystatin	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Pancreatin, B.P............................. Pancreatin Enzyme U.S.N.F. XI...	Fibrocystic disease Pancreatico-duodenectomy Pancreatic steatorrhoea
Para-Aminosalicylic Acid............	Tuberculosis
Paracetamol Suspension................ Paracetamol Tablets, B.P..............	Any disease or condition in a pensioner
Paracetamol with Codeine Phosphate and Pentobarbitone Sodium	Any disease or condition in a pensioner
Paramethasone Acetate.................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion.............. Paraffin Liquid Emulsion with Phenolphthalein	Any disease or condition in a pensioner
Pargyline Hydrochloride...............	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Penicillamine.................................	With the written authority of the Director-General— Cystinosis Cystinuria with calculus formation Treatment of cold agglutinin haemoglobinuria Acute heavy metal intoxication Wilson’s Disease (hepatolenticular degeneration)
Penicillin Benzathine Tablets and Capsules Penicillin Benzyl Tablets, B.P...... Penicillin Benzyl Capsules...........	Prevention of recurrent streptococcal infections, including rheumatic fever
Benzylpenicillin injection 5,000,000 units and 10,000,000 units	Bacterial endocarditis or septicaemia
Benzylpenicillin with Streptomycin Sulphate Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Pethidine Hydrochloride with Levallorphan Tartrate	Obstetrical use
Phenylbutazone Tablets B.P......... Phenylbutazone Capsules	Acute attacks of gout Osteoarthritis or Rheumatoid Arthritis not responding to salicylates
Phytomenadione Injection, B.P. Pituitary, Posterior Lobe, Insufflation	Antidote to anticoagulants Diabetes insipidus
Polymyxin B. Sulphate Injection..	Any disease or condition in a patient receiving treatment in or at an approved hospital
Polyocstradiol Phosphate..............	Carcinoma of the prostate
Prednisolone Sodium Phosphate	With the written authority of the Director-General—
Retention Enema and Suppository	Ulcerative colitis proven by sigmoidoscopy or radiological report Proctitis proven by sigmoidoscopy
Prednisolone Tablets, B.P.............	With the written authority of the Director-General— Cerebral oedema; Cerebral tumors; Acute exophthalmic ophthalmoplegia; Interstitial keratitis due to syphilis or vernal conjunctivitis; Malignancy treatment in conjunction with radiotherapy or chemotherapy; Acute heart block complicating myocardial infarction; Benign intracranial hypertension; Encephalatis; Malignant exophthalmos; Meningitis; Nodular non-suppurative panniculitis (Christian-Weber disease); Oedema of the spinal cord following trauma or infection; A disease or condition specified in this column in relation to Cortisone Injection except total adrenalectomy or Addison’s disease or andrenocortical hypoplasia
Prenisolone Acetate Injection....... Prednisolone Methyl Acetate Injections Prednisolone Tertiary Butyl Acetate Injections Prednisolone Trimethylacetate Injections	Intra-articular use
Methylprednisolone Tablets, B.P. Methylprednisolone Capsules.......	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisolone Sodium Hemisuccinate	Acute adrenal failure due to medical or surgical crises Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy Stevens-Johnson syndrome
Prednisone Tablets, B.P................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Procarbazine Hydrochloride.........	Any disease or condition in a patient receiving treatment in or at an approved hospital
Progesterone..................................	Habitual abortion Progesterone deficiency proven by hormonal assay of lateral wall smear
Propranolol Hydrochloride........... Pyrazinamide.................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridostigmine Injection, B.P....... Pyridostigmine Tablets, B.P.........	Myasthenia gravis
Pyridoxine Hydrochloride Tablets	Peripheral neuritis due to isoniazid therapy Radiation sickness
Quinine Bisulphate Tablets, B.P... Quinine Dihydrochloride Tablets.. Quinine Hydrochloride Tablets..... Quinine Sulphate Tablets, B.P......	Dystrophia myotonica Malaria Myotonia atrophica Myotonia congenita
Riboflavine Tablets....................... Senna Fruit Extract (Standardised) Sobee........................................	Any disease or condition in a pensioner
With the written authority of the Director-General— Galactosaemia Homocystinuria Lactose intolerance Milk allergy in children under the age of four years
Sodium Aminosalicylate Tablets, B.P. Sodium Aminosalicylate Injection Sodium Aminosalicylate Cachets Sodium Aminosalicylate Granules Sodium Aminosalicylate with Isoniazid B.P............................................	Tuberculosis
Sodium Folate	Macrocytic anaemia Sprue or the sprue-like syndrome
Spiramycin....................................	Serologically proven active toxoplasmosis Staphylococcal septicaemia or staphylococcal pneumonia Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins
Spironolactone Tablets, B.P.........	With the written authority of the Director-General, to supplement other diuretics when these have proved inadequate Myasthenia Gravis
Stanolone......................................	Mammary carcinoma With the written authority of the Director-General, Intermittent use for corticosteroid-induced osteoporosis
Stanozolol.....................................	With the written authority of the Director-General, Intermittent use for corticosteroid-induced osteoporosis
Stilboestrol Injection..................... Stilboestrol Tablets, B.P...............	Carcinoma of the prostate Mammary carcinoma Any disease or condition in a pensioner Heriditary Telangiectasis
Streptomycin Sulphate Injections.	Bacillary dysentery that is resistant to the Sulphonamides Brucellosis Chancroid Endocarditis due to Streptococcus faecalis or Streptococcus viridans Friedlander bacillus infections Haemophilus influenzae infections Plague Pseudomonas pyocyanea infections Rat-bite fever (Streptobacillus moniliformis) Salmonella infections Surgical conditions of the bowel (pre-operative and postoperative) Surgical conditions of the thoracic organs Tuberculosis

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Streptomycin Sulphate Injections— continued	Tularaemia Urinary tract infections that are resistant to the Sulphonamides
Sulphasalazine...............................	Ulcerative colitis
Sulphomyxin Sodium...................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Sultiame........................................	For use where other anticonvulsants have failed
Surgical Cement............................ Surgical Cement Solvent..............	Ileostomy or colostomy conditions
Sustanon........................................ Testosterone Implants, B.P........... Testosterone Oenantliate.............. Testosterone Proprionate Injection, B.P. Methyltestostcrone Tablets, B.P... Methyltestosterone, B.P.	Castration syndrome (male) Klinfelter Reifenstein Albright syndrome Mammary carcinoma
Tetanus Antitoxin, B.P. (Bovine).	Patients known to be sensitive to horse serum
Tetanus Immune Globulin (Human)	With the written authority of the Director-General, where patients are known to be sensitive to horse serum and cattle serum
Tetracosactide...............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tetracycline Capsules, B.P........... Tetracycline Tablets, B.P.............. Tetracycline Injections.................. Rolitetracycline............................. Tetracycline Hydrochloride Granules, Paediatric Drops and Syrup Tetracycline with a buffering agent	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Tetracycline with a buffering agent and Amphotericin B Tetracycline with a buffering agent and Nystatin	A disease or condition specified in this column in relation to Oxytetracycline Hydrochloride with a buffering agent and Nystatin
Thiambutosine Tablets, B.P.......... Thiambutosine Injection...............	Hansen’s disease
Thiethylperazine Tablets and Suppositories............................	With the written authority of the Director-General— Radiation sickness
Thioridazine Tablets, B.P............. Thioridazine..................................	Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General— Late-stage malignancy Radiation sickness With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Thyrotrophin.................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tragacanth, Indian (Gum Karaya) Trasylol.....................................	Ileostomy or colostomy conditions
Any disease or condition in a patient receiving treatment in or at an approved hospital
Tretamine......................................	Malignant lymphoma and related conditions

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Triamcinolone................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Trifluoperazine Tablets, B.P......... Trifluoperazine Hydrochloride, B.P.	Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital With the written authority of the Director-General— Late-stage malignancy Radiation sickness With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Trimetaphan Injection, B.P...........	Hypotensive for anaesthesia
Vadrine.........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vasopressin Nasal Spray..............	Diabetes insipidus
Velactin.........................................	With the written authority of the Director-General— Galactosaemia Homocystinuria Lactose intolerance Milk allergy in children under the age of four years
Vinblastine Sulphate.....................	Hodgkin’s disease
Vincristine Sulphate......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Viomycin Sulphate....................... Viomycin Sulphate Injection, B.P.	Tuberculosis
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra

Actions

Download as PDF Download as Word Document

Citations

National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0